Agilent Technologies stock higher as 4Q results beat estimates
Agilent Technologies (NYSE:A) Inc after Monday's close announced fourth quarter 2023 financial results that exceeded expectations on both the top and bottom lines. The analytical and clinical labo...
3 Biotech Stocks With Big-Time Breakthrough Potential
In a world in constant evolution and growth, more and more companies are needed that are committed to development and research in the health area. These biotech companies are not only doing the job...
Earnings Exchange: Medtronic, Agilent Technologies & Trip.com
Ari Wald, managing director and head of technical analysis at Oppenheimer, joins 'The Exchange' to discuss Medtronic, Agilent Technologies, and Trip.com.
Agilent Technologies' overexposure to China headwinds prompts analyst downgrade
Agilent Technologies (NYSE:A) has been downgraded from ‘Buy' to ‘Neutral' by UBS analysts who believe that the life sciences and diagnostics company's overexposure to regional headwinds in China, i...
What to Note Ahead of Agilent Technologies' (A) Q4 Earnings
Agilent's (A) results for the fiscal fourth quarter are expected to reflect strength across the ACG amid weakness in the LSAG segment.
Agilent Technologies (A) Beats Stock Market Upswing: What Investors Need to Know
In the closing of the recent trading day, Agilent Technologies (A) stood at $113.60, denoting a +1.78% change from the preceding trading day.
Agilent raises dividend by 5%
Agilent Technologies Inc. A, +1.78% late Wednesday said it has increased its dividend 5% to 23.6 cents a share. The dividend will be paid on Jan. 24 to shareholders of record as of the close of bus...
Agilent Technologies (A) Stock Dips While Market Gains: Key Facts
Agilent Technologies (A) reachead $109.39 at the closing of the latest trading day, reflecting a -1.04% change compared to its last close.
Agilent (A) Bolsters NTD Research With SIDC Partnership
Agilent (A) collaborates with Sarawak Infectious Disease Centre to provide the latter with its 6475 triple quadrupole LC/MS system, enabling rapid outbreak response for neglected tropical diseases.
Agilent Not As Agile As Hoped As Life Sciences Demand Proves To Be Less Than Invincible
Demand from biopharmas for life sciences equipment has not sustained high expectations in 2023, leading to weaker growth and negative revisions for companies like Agilent. Biopharma and industrial ...
Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
The Healthcare sector has seen a modest bid since mid-July compared to the S&P 500, with a reach for perceived safety. Agilent Technologies is a leading supplier in the Life Sciences Tools and Serv...
Illumina names Agilent executive as new CEO
Illumina Inc. ILMN, +1.96% on Tuesday announced that its board has appointed Agilent Technologies Inc. A, +0.69% senior vice president Jacob Thaysen as its new CEO, effective Sept. 25. The DNA sequ...
Agilent (A) Q3 Earnings Beat Estimates, Revenues Fall Y/Y
Agilent Technologies' (A) third-quarter fiscal 2023 results reflect weakness in the LSAG segment and China market.
Agilent Technologies, Inc. (A) Q3 2023 Earnings Call Transcript
Agilent Technologies, Inc. (NYSE:A ) Q3 2023 Earnings Conference Call August 15, 2023 4:30 PM ET Company Participants Parmeet Ahuja - IR Mike McMullen - President and CEO Robert McMahon - SVP and C...
Markets Remain Sold; H&R Block (HRB), Agilent (A) Beat
The Dow slid -360 points in today's trading session, -1.02%, while the Nasdaq was down -157 points, -1.14%.
Related Companies